Apontis Pharma AG Cash Flow Reinvestment Rate
Apontis Pharma AG cash flow reinvestment rate. Apontis Pharma AG (APPH) has a Cash Flow Reinvestment Rate of 0.01x as of December 2024, reinvesting €5.60K (capex €5.60K ) from operating cash flow of €905.24K. Explore Apontis Pharma AG (APPH) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Apontis Pharma AG (2020–2022)
Cash flow reinvestment rate of Apontis Pharma AG from 2020 to 2022. Historical reinvestment intensity for Apontis Pharma AG across 3 annual periods. Explore Apontis Pharma AG capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Apontis Pharma AG Cash Flow Reinvestment Rate by Year (2020–2022)
Apontis Pharma AG cash flow reinvestment rate by year from 2020 to 2022. Year-by-year capital reinvestment analysis for Apontis Pharma AG. For the full cash flow conversion analysis, see APPH cash generation efficiency.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.54x | €5.96 Million | €11.02 Million | €3.28 Million | ▼ -45.9% |
| 2021 | 1.00x | €3.43 Million | €3.43 Million | €1.66 Million | ▼ -3.7% |
| 2020 | 1.04x | €1.51 Million | €1.45 Million | €729.56K | — |